Diabetes Treatment Weblog

Posts Tagged ‘drugs’

Nursing Andalusian begin this month the second phase of nurse prescribing, as it will allow them to collaborate in the process of indication and monitoring of drug therapies for diabetes and chronic wound care, in what is called collaborative prescribing.

The Minister of Health, María Jesús Montero, who today opened the IX Congress of the Andalusian Society of Community Nursing (ASANEC) being held in Seville, was referring to the second development phase of the decree so far given to this group Professional 96 indicate the possibility of non-prescription drugs and medical devices such as catheters, sterile dressings, absorbent urinary incontinence, and test strips to measure blood glucose among others.

Read the rest of this entry »

Patients treated for long periods with metformin, a common drug for diabetes, are at risk of developing a deficiency of vitamin B12, which also can worsen over time, according to a study published on Friday.

Netherlands scientists said the results suggest that they should “seriously consider” regular monitoring of vitamin B12 levels during prolonged treatment with metformin to try to prevent deficiency and its effects.

Read the rest of this entry »

Since 2007 in Germany is going a combined therapy of the drug pioglitazone with insulin. First interim analysis was recently published. These indicate that the combination in the future is both effective and safe.

The type 2 diabetes
Type-2 diabetes have a resistance of body cells to the biological effects of insulin. Once this so-called insulin resistance is too strong, does the injected insulin in a diabetes therapy is not effective enough. Be increased in these cases, the insulin sensitivity by insulin sensitizers. These sensitizers are firstly used for type-2 diabetes with marked insulin resistance, ie, in patients in whom insulin alone is insufficient. On the other hand in diabetic patients who are not the standard combination of insulin and metformin because of contraindications or intolerance can take.

Read the rest of this entry »

In Germany, a type-2 diabetes is often treated with tablets. These are relatively easy to handle and do not require intensive training as they are common for insulin users. Nevertheless, type-2 diabetes have a relatively high risk for atherosclerosis and heart disease. A new study has dealt with the question of which treatment option for type 2 diabetes cheap.

Read the rest of this entry »

Gestational diabetes is a specific disorder that occurs during pregnancy, which is distinguished by an increase in blood glucose, among other conditions, but that after birth the baby and usually disappears during the postpartum period.

This is because during pregnancy the placenta produces hormones such as estrogen, cortisol and lactogen, which can block the work of insulin, which is responsible for regulating blood glucose. When gestational diabetes is not treated, can cause severe consequences on the health of the pregnant woman and baby, one of the most common infections are usually in the urinary tract.

Read the rest of this entry »

According to the National Eye Institute of the United States, the drug Lucentis company Roche AG works better than the exclusive use of lasers to treat a common type of blindness in people with diabetes.

At a conference sponsored by the institute, the Network of Diabetic Retinopathy Clinical Research, reported that: “Lucentis, known generically as ranibizumab, was much more effective than single treatment with laser in various types of retinal problems.”

Read the rest of this entry »

If diet and exercise do not help to maintain normal or near normal blood glucose, your doctor may prescribe medication. Because these drugs help to lower blood sugar levels in different ways, the doctor might take more than one. These drugs can be used in conjunction with insulin, if necessary.

Read the rest of this entry »

Care of patients with diabetes mellitus is kept to a minimum the risk of microvascular and macrovascular complications, maintaining normal blood pressure, lipid profile and blood glucose.

Glycemic control is to maintain glycosylated hemoglobin (HbA1c) between normal limitted, because we know that good glycemic control reduces the long-term risk of microvascular complications in both types of diabetes, 1 and 2. Researchers at ADVANCE and ACCORD studies examined the effect of glycemic control on the evolution of patients with type 2 diabetes and macrovascular and microvascular disease. Both studies failed to demonstrate that good glycemic control is associated with reduced cardiovascular risk.

Reports of a potential increase in mortality rates associated with intensive glycemic control resulted in a debate on the recommendations for the treatment of type 2 diabetes, specifically aiming to establish an optimal HbA1c. Researchers have suggested that in diabetics, hypoglycemia is a possible increased risk of mortality. Because intensive glycemic control increases the risk of hypoglycemia, with some drugs than with others, it is important to assess the risks associated with the various schemes to lower blood sugar. In two meta-analysis, researchers pooled data from several major works and concluded that intensive glycemic control has a positive effect on cardiovascular outcomes. However, these meta-analysis were limited by the limitations of clinical trials analyzed.

Read the rest of this entry »

As you know very restrictive diets can help you lose weight in a matter of days, but are harmful to your health and no effective long term. That’s why I propose you something much better, almost imperceptible changes in your diet and lifestyle, but that will impact significantly on your health and your body.

Join the club of small things!

Read the rest of this entry »

Are diabetes drugs can kill? This may be the lesson of a study presented at the recent convention of the American Diabetes Association (ADA) in San Francisco. In the ACCORD study, more than 10,000 diabetic patients were randomly divided into two groups, one with intent to moderately reduce glucose levels in blood and another with intent to reduce them aggressively.

Aggressively treated patients had a much lower level of blood glucose (but still slightly above normal) than patients less medicated. After 3 years and 6 months, there were no differences between the two groups in the development of cardiovascular disease (one of the major complications of diabetes). Incredibly, those in the aggressively treated group had a 22 percent increase in risk of mortality.

Read the rest of this entry »